Results 221 to 230 of about 67,846 (274)
Clinical and electrophysiological characteristics of myasthenia gravis patients with concomitant type 2 diabetes mellitus. [PDF]
Front NeurolLi XM +6 more
europepmc +1 more source
Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study. [PDF]
J NeurolLin J +10 more
europepmc +1 more source
Evaluation of Muscle Oxygenation by Functional Near-Infrared Spectroscopy in Patients with Myasthenia Gravis During Rest and Exercise. [PDF]
Noro Psikiyatr ArsSemiz EC +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2016
Myasthenia gravis is an autoimmune disease, which leads to load-dependent weakness of voluntary skeletal muscles with recovery of function after resting. The disease is caused by autoantibodies directed against the postsynaptic nicotinic acetylcholine receptors (AChR) leading to a reduction of neuromuscular transmission.
PRIOLA, adriano massimiliano +2 more
openaire +8 more sources
Myasthenia gravis is an autoimmune disease, which leads to load-dependent weakness of voluntary skeletal muscles with recovery of function after resting. The disease is caused by autoantibodies directed against the postsynaptic nicotinic acetylcholine receptors (AChR) leading to a reduction of neuromuscular transmission.
PRIOLA, adriano massimiliano +2 more
openaire +8 more sources
Seminars in Neurology, 1990
The treatment of patients with myasthenia gravis should be individualized according to the extent (ocular versus generalized) and severity (mild to severe) of disease, the presence or absence of concomitant disease (including but not limited to other autoimmune diseases and thymoma), and, to a lesser degree, the age of the patient. Thymectomy should be
D M, Linton, D, Philcox
openaire +4 more sources
The treatment of patients with myasthenia gravis should be individualized according to the extent (ocular versus generalized) and severity (mild to severe) of disease, the presence or absence of concomitant disease (including but not limited to other autoimmune diseases and thymoma), and, to a lesser degree, the age of the patient. Thymectomy should be
D M, Linton, D, Philcox
openaire +4 more sources
Seminars in Neurology, 2015
Myasthenia gravis is an autoimmune neuromuscular disease caused by antibodies directed against the postsynaptic muscle membrane. The clinical hallmark of the disease is fluctuating and fatigable weakness that affects the ocular muscles (resulting in diplopia and ptosis), the bulbar muscles (causing dysphagia, dysarthria, and dyspnea), and extremity ...
Kelly G, Gwathmey, Ted M, Burns
openaire +3 more sources
Myasthenia gravis is an autoimmune neuromuscular disease caused by antibodies directed against the postsynaptic muscle membrane. The clinical hallmark of the disease is fluctuating and fatigable weakness that affects the ocular muscles (resulting in diplopia and ptosis), the bulbar muscles (causing dysphagia, dysarthria, and dyspnea), and extremity ...
Kelly G, Gwathmey, Ted M, Burns
openaire +3 more sources
Neuropediatrics, 1985
A review of twelve Southern Chinese children whose myasthenic symptoms started within the first two years of life and followed up for one to sixteen years showed that, unlike some previous reports on non-Chinese children, the majority had only ocular myasthenia.
W Y, Chan-Lui, B R, Hawkins
openaire +2 more sources
A review of twelve Southern Chinese children whose myasthenic symptoms started within the first two years of life and followed up for one to sixteen years showed that, unlike some previous reports on non-Chinese children, the majority had only ocular myasthenia.
W Y, Chan-Lui, B R, Hawkins
openaire +2 more sources
Neurologic Clinics, 2018
Ocular myasthenia is a form of myasthenia gravis in which weakness is restricted to the ocular muscles and may produce significant visual disability. Patients present with fluctuating ptosis, diplopia, or a combination of both. Examination may show any type of ocular motility deficit ranging from isolated muscle palsy to complete ophthalmoplegia. Cogan
Mohammed, Al-Haidar +2 more
openaire +2 more sources
Ocular myasthenia is a form of myasthenia gravis in which weakness is restricted to the ocular muscles and may produce significant visual disability. Patients present with fluctuating ptosis, diplopia, or a combination of both. Examination may show any type of ocular motility deficit ranging from isolated muscle palsy to complete ophthalmoplegia. Cogan
Mohammed, Al-Haidar +2 more
openaire +2 more sources